Saluggia – DiaSorin S.p.A. (“DiaSorin”; FTSE MIB: DIA) announces it has received all approvals necessary to complete the acquisition of Luminex Corporation (“Luminex”; NASDAQ:nLMNX). After the approval by Luminex shareholders, and having received all clearances from applicable regulatory authorities, including the Committee on Foreign Investment in the United States (CFIUS), DiaSorin expects the acquisition to […]
SAN FRANCISCO — Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, today announced that it has signed a definitive agreement to acquire the STARLIMS informatics product suite and related business assets from Abbott (NYSE: ABT). Abbott is a global healthcare company with leading businesses and products in diagnostics, medical […]
Göttingen Portfolio expanded by cell culture components, such as growth factors, cytokines, and media CellGenix site in Freiburg to be expanded into a center of excellence for the development and production of cell culture components The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer […]
Techcomp Instruments Limited (“Techcomp”) is delighted to announce that Techcomp Europe has successfully completed the acquisition of a majority shareholding in Isotopx Limited, based in Middlewich, Cheshire. For the past 13 years Isotopx has been at the forefront of mass spectrometer design and innovation. The whole team at Isotopx, led by CEO and founder Zenon […]
As announced on June 26, 2021, CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire Discover Echo Inc. (“Discover Echo”), an innovative and revolutionary American company focusing on development, manufacturing, and sales of patented and unique hybrid microscopes that easily transform between Upright and Inverted configurations, merging the capabilities of multiple instruments into one. […]
— Accelerates Conversion from Microarray to Genotyping by Sequencing– — Expands NGS Capabilities into New Markets — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the acquisition of iGenomX, a company offering multiplex library […]
Combined with Cytiva’s existing manufacturing in Logan, Utah, Intermountain will boost global production of buffers and liquid cell culture media to Cytiva’s customers Responds to increased demand for products that are used in emerging modalities such as gene therapy, and are currently in high demand for the manufacture of COVID-19 vaccines and therapies Cytiva intends […]
Transaction will expand BioIVT’s in vitro diagnostic, cell and gene therapy support capabilities Westbury, NY – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the acquisition of Valley Biomedical Products & Services, Inc. located in Winchester, VA. Founded in 1986, Valley Biomedical provides specialized biological products and services for the […]
WELLESLEY, Mass. — Ampersand Capital Partners announced today that it has completed the sale of Nexcelom Bioscience, one of its portfolio companies and a leading provider of automated cell counting solutions, to PerkinElmer for $260 million in cash. Founded in 2003 and headquartered in Lawrence, Massachusetts, Nexcelom is the manufacturer of innovative Cellometer, Cellaca MX, and Celigo image cytometry […]
● Integrated single software platform will enable true patient-centric precision oncology at scale for cancer patients care combining medical, germline, somatic and liquid biopsy data analysis together. ● Cambridge Cancer Genomics OncOS machine learning oncology software will be integrated in Dante Labs CE-IVD, ISO13485 Immensa Genomics Interpretation Software, and it will become available to clinical […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
